G01N 33/9466
Antidepressants
Official title: {Antidepressants}
G01N33/9466 (Antidepressants) appears on 38 US grants and 35 published applications in this corpus.
Search patents in G01N- Granted patents
- 38
- Published applications
- 35
- Assignees
- 31
- Inventors
- 79
- Latest grant
- 31 Aug 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 4 |
| 2004 | 1 | 1 |
| 2005 | 2 | 2 |
| 2006 | 2 | 1 |
| 2007 | 1 | 1 |
| 2008 | 2 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 6 |
| 2015 | 1 | 2 |
| 2016 | 2 | 3 |
| 2017 | 2 | 1 |
| 2018 | 0 | 1 |
| 2019 | 3 | 3 |
| 2020 | 1 | 2 |
| 2021 | 2 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibodies to quetiapine and use thereof31 Aug 2021US 11,104,742 B2Janssen Pharmaceutica NV
- Blood biomarkers for suicidality29 Jun 2021US 11,047,009 B2Indiana University Research and Technology Corporation
- Rapid and sensitive method of forensic toxicology in post-mortem subjects and in live and post-mortem animals using oral fluid testing25 Aug 2020US 10,753,952 B2
- Antibodies to quetiapine haptens and use thereof5 Nov 2019US 10,465,013 B2Janssen Pharmaceutica NV
- Antibodies to quetiapine and use thereof8 Oct 2019US 10,435,478 B2Janssen Pharmaceutica NV
- Rapid Method of Forensic Toxicology in Post-Mortem Individuals Using Muscle Tissue Testing12 Mar 2026US 2026/0072046 A1
- Method for simultaneous and efficient detection of residues of 36 antidepressants in sludges24 Oct 2024US 2024/0353434 A1Institute of Microbiology, Guangdong Academy of Sciences (Guangdong Detection Center of Microbiology
- Gpcr screening method to identify non-hallucinogenic compounds30 Nov 2023US 2023/0384333 A1The Regents of the University of California
- Rapid Method of Forensic Toxicology in Post-Mortem Individuals Using Muscle Tissue Testing25 Feb 2021US 2021/0055316 A1
- Antibodies to quetiapine haptens and use thereof21 Jan 2021US 2021/0017294 A9Janssen Pharmaceutica NV
Most cited
By later US patents
- Reagents and methods for the quantification of total doxepins in biological fluids30US 5,332,661 AAbbott Laboratories · 1994
- Tricyclic antidepressant drug immunogens, antibodies, labeled conjugates, and related derivatives27US 4,495,281 AMiles Laboratories, Inc. · 1985
- Tricyclic antidepressant conjugates with antigens and enzymes25US 4,629,691 ASyntex (U.S.A.) Inc. · 1986
- Antibodies to quetiapine and use thereof17US 9,410,972 B2Janssen Pharmaceutica NV · 2016
- Antibodies to quetiapine haptens and use thereof16US 9,850,318 B2Janssen Pharmaceutica NV · 2017